Buy a Dental Practice in New Mexico: Receipt Review

Start with the receipt file the New Mexico buyer can explain

A practice can have clean bank records and still have a weak tax workpaper. The bank proves that money arrived. It does not explain the payer's contract, the patient's share or the reason an amount was deducted. Before relying on reported earnings, ask how the practice moves from each receipt to its reporting treatment.

The useful output is a receipt schedule that another reviewer can follow. Each row should identify the recipient, period, payment source and supporting record. It should also show the amount already assigned to another tax treatment. A single column called insurance does not supply that detail.

Set the review period before requesting exports. Use the same entity and reporting period across the receipt file, workpapers and filed returns. If the practice changed software, obtain a bridge between the old and new labels. Keep a receipt's original identifier so that a revised export does not make the same money appear twice.

This review belongs within the broader practice acquisition guide. It can explain a historical cost or identify an unresolved assumption. It does not prove the value of the practice, authorize the buyer to provide care or establish the buyer's future payer arrangements.

Read the current provision before copying a familiar label

The state's July 2026 tax compilation, Section 7-9-93 covers specified commercial-contract and Medicare Part C receipts, subject to its payer, practitioner and service conditions. Its practitioner definition includes licensed dentists and hygienists. It separately addresses qualifying patient copayments and deductibles before July 1, 2028. Other allowable deductions come first, and this deduction has separate reporting requirements. Insurer fee-for-service payments, as defined there for indemnity plans, are excluded from this provision.

Those distinctions make the underlying agreement important. The office's everyday phrase fee for service may not describe the statutory category. Ask the tax adviser to state which meaning is being used. Keep the clinical billing label and the tax conclusion in separate fields if their meanings differ.

Version control also matters. The Legislature's 2026 HB338 record shows that the bill died. Its proposed changes should not be treated as enacted terms. The July 2026 compilation still displays older regulatory language excluding patient copayments alongside the newer statutory provision. Have the tax reviewer reconcile that conflict; copying the old exclusion is not a sound review method.

Date the conclusion and attach the authority actually used. A downloaded file with a recent retrieval date can contain much older text. The reviewer should distinguish a current compilation, a dated explanation and a proposal. This prevents a seller's old template from quietly becoming the buyer's operating assumption.

Match patient payments to their supporting terms

TRD's FYI-202, revised May 2024, explains that not every patient payment qualifies as a copayment or deductible. The plan terms and payment's character matter. It also distinguishes a claims administrator paying an otherwise qualifying receipt from a third party earning fees for administration. This is dated agency guidance, not an individual ruling. Compare its explanation with the applicable law before relying on it.

Build an evidence request around those differences. A card receipt proves a payment method. It does not, by itself, show how the plan assigned the patient's share. An account note saying balance paid may be equally incomplete. Ask for the smallest lawful set of records that can resolve the classification.

Use the due diligence checklist to place these requests alongside financial and operating records. Avoid sending a broad demand for every patient chart when a controlled receipt sample and plan evidence can answer the question.

Worked case: allocate one receipt file once

Assume a fictional New Mexico buyer reviews one $250,000 receipt file for a single reporting period. All amounts are distinct, with no refunds, reversals, duplicated exports or timing differences. Qualified advisers have supplied the classifications described below for teaching purposes. The case does not determine whether any real taxpayer qualifies.

The first row has an assumed supported deduction under another provision. The model does not specify that provision or ask the reader to infer it from a payer name. The next two rows have assumed support for the stated treatment after that first allocation. The unresolved row stays unresolved until the missing facts are assessed.

The new supported amount is $145,000 plus $25,000, or $170,000. With the separately supported $30,000, the file has $200,000 allocated and $50,000 remaining. That remainder is a review result. It is not a tax bill or a conclusion that every remaining dollar has the same tax treatment.

The order can be checked another way. Start with $250,000 and remove the earlier $30,000 allocation. The remaining pool is $220,000. Remove the new $170,000 supported amount and $50,000 remains. Both routes agree because the earlier allocation is used once.

Now test a flawed spreadsheet. Suppose its payer column includes the earlier $30,000 as well as the separate $145,000. It deducts $175,000 plus the supported patient $25,000 after taking the earlier $30,000. The resulting $20,000 remainder is $30,000 too low. The file has not produced another deduction; it has reused the same dollars.

Change evidence without changing the receipts

A useful sensitivity test changes one fact at a time. Keep the $250,000 file intact and return to the original assumptions for each branch. This makes the effect of new support visible without mixing it with a change in collections.

The confirmation branch does not add $8,000 of cash. It changes where existing receipts sit in the workpaper. The withdrawal branch does not mean the practice lost $12,000 of patients or collections. It changes the support for an assumed treatment. Both changes together increase the original remainder by $4,000.

Give each change a record of its reason, reviewer and date. Retain the original workpaper so the buyer can see what changed. An overwritten total with no explanation is hard to challenge or reproduce, even when its arithmetic is correct.

If the underlying payment itself changes, create a separate branch. A refund, reversal or newly located receipt changes the file being reviewed. That is a different question from receiving better support for an amount already in it. Do not use the evidence sensitivity to conceal a changed receipt population.

Carry the review into earnings with a clear boundary

The buyer's next question is how the reviewed tax cost affects the proposed operation. Give the adviser the actual entity, services, contracts, location and reporting facts. Then obtain the supported cost treatment for those facts. This guide deliberately supplies no tax rate, purchase-price multiple or standard allowance.

The payer-mix guide addresses revenue quality and dependence on payment sources. Use it alongside this receipt review. A high share of one payer can be commercially significant even if its tax treatment is well documented. A supported deduction does not prove that the payer's rates or patient volume will continue.

Reconcile any corrected tax cost to the earnings workpaper once. Identify whether the reported expense was booked, paid, accrued or omitted. Keep a historical correction separate from a proposed future cost. Otherwise, a buyer can subtract the same item twice or treat a one-time catch-up amount as a recurring operating cost.

Do the same with cash planning. A workpaper correction is not cash reserved in a bank account. The working capital guide helps keep funds available for payroll and other uses distinct from a tax estimate. Ask who will fund each actual obligation and when, based on the agreed transaction terms.

Assign the follow-up to someone who can complete it

Make the open-item list specific. Replace verify taxes with a task such as reconcile these receipt identifiers to the stated support. Name the source record, person responsible and next review date. Give the adviser room to request a different document if the first one does not answer the question.

TRD's Forms and Publications page says that someone other than the taxpayer needs its Tax Information Authorization form to speak with a department representative on the taxpayer's behalf. An NDA or purchase agreement should not be treated as that form. Have the appropriate parties confirm the authority needed for an actual inquiry.

The department's FYI-105 dated August 11, 2025 is an overview for July 2025 through June 2026. It warns that later authority can change its contents and that the publication is not a ruling. Use the current reporting instructions for an actual filing and seek a case-specific answer where the facts remain unclear.

Keep payer access on its own list. The credentialing guide addresses incoming arrangements. A tax classification of the seller's receipts does not settle the buyer's enrollment, contract or payment rights. Record the unresolved dependency rather than filling the gap with an assumed approval.

Stage disclosure and protect the people in the file

Keep initial seller outreach blind. Do not include the seller's identity, exact address or identifying operating detail in early buyer approaches. Put an NDA in place before identifying disclosure, then release information in stages suited to the buyer's role and actual need. Use the confidential diligence guide to define that process.

Coordinate staff participation with the seller. A billing lead may be needed to explain an old code or export a narrow report. Tie that involvement to the task, preparation and applicable duties. Do not announce the sale to the whole office merely because one person needs to help with a workpaper.

Patient information requires separate authority and privacy review. The transaction NDA does not supply that authority. Use masked examples and nonidentifying totals where they suffice. When patient-level evidence is needed, have the responsible professionals determine the lawful access, handling and retention process before releasing it.

Keep the record of disclosure separate from the tax conclusion. A person may be permitted to review a file without being qualified to decide its tax treatment. Clear roles make it easier to route questions and limit repeated requests to staff.

Common mistakes in a New Mexico receipt review

The first mistake is treating an office label as proof. Insurance, patient pay and fee for service can hide several different arrangements. Trace the amount to the relevant facts before assigning a conclusion.

The second is using the same money in more than one deduction column. Reconcile the final allocations to the distinct receipt population. A correct formula does not cure overlapping inputs.

The third is promoting uncertain support into a confirmed amount because the deal is close to signing. Keep the unresolved amount visible, state what would resolve it and let the parties assess the effect on their decision. Do not turn uncertainty into an unsupported tax estimate.

The fourth is carrying a historical conclusion into the buyer's operation without checking the changed facts. The buyer may use a different entity, contract or service arrangement. A dated file provides a starting point for review, not a permanent answer.

Summary: make the receipt decision reproducible

A useful New Mexico buyer file shows where each amount came from, what support was reviewed and which allocation used it. It separates evidence changes from changes in cash. It also leaves a clear path for the tax adviser to resolve uncertain items before those items become assumptions in the acquisition budget.

Bring the supported schedule, original workpapers and open questions into the transaction review. Ask for an explanation that can be repeated from the source records. That is more useful than a single claim that the practice's receipts are deductible.